Solaris Pharma Corporation
Pharmaceuticals, 1031 Us Hwy 202206, Bridgewater, New Jersey, 08807, United States, 11-50 Employees
Phone Number: 90********
Who is SOLARIS PHARMA CORPORATION
Solaris Pharma Corporation was founded in 2014 with the vision of improving the patients quality of life through development of niche pharmaceutical products. Located in Bridgewater, New ...
Read More
-
Headquarters: 1031 Us Hwy 202206, Bridgewater, New Jersey, 08807, United States
-
Date Founded: 2014
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
-
CEO:
Satish Pejaver
Email
Phone
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from SOLARIS PHARMA CORPORATION
Solaris Pharma Corporation Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Solaris Pharma Corporation
Answer: Solaris Pharma Corporation's headquarters are located at 1031 Us Hwy 202206, Bridgewater, New Jersey, 08807, United States
Answer: Solaris Pharma Corporation's phone number is 90********
Answer: Solaris Pharma Corporation's official website is https://solaris-pharma.com
Answer: Solaris Pharma Corporation's revenue is $10 Million to $25 Million
Answer: Solaris Pharma Corporation's SIC: 2834
Answer: Solaris Pharma Corporation's NAICS: 325412
Answer: Solaris Pharma Corporation has 11-50 employees
Answer: Solaris Pharma Corporation is in Pharmaceuticals
Answer: Solaris Pharma Corporation contact info: Phone number: 90******** Website: https://solaris-pharma.com
Answer: Solaris Pharma Corporation was founded in 2014 with the vision of improving the patients quality of life through development of niche pharmaceutical products. Located in Bridgewater, New Jersey, Solaris Pharma Corporation has a fully equipped Research & Development facility with expertise in the development of generic and specialty products. Solaris Pharma Corporation is uniquely poised to develop specialty dermatology products that have a relatively high barrier to entry due to manufacturing complexities and high-end clinical patient study demands. With a thorough knowledge of the development life cycle and well-trained, committed scientific personnel, Solaris Pharma Corporation has streamlined processes that are efficient in reducing development costs and shortening timelines, without compromise in quality. Solaris Pharma Corporation is currently engaged in the development of several generic dermatology products and is committed to establish itself as a pacesetter in dermatology pharmaceuticals.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month